title: Abnormal prostate development in C3(1)-bcl-2 transgenic mice.
abstract: BACKGROUND
  Recent hypotheses to explain the etiology of abnormal growth associated with prostate disease have invoked perturbations in the rate of apoptosis as an important contributor to the onset and progression of these diseases. For this reason, the apoptosis suppressing oncoprotein bcl-2 has come under scrutiny with regards to its role in prostate diseases. In order to evaluate the role of bcl-2 in human prostate disease and to develop an animal model to test anti-bcl-2 therapies, we generated transgenic mice in which bcl-2 expression is targeted to the mouse prostate gland.
  
  
  METHODS
  Mouse embryos were microinjected with recombinant DNA constructed by fusing a modified rat C3(1) promotor element to cDNA encoding human bcl-2. Presence of the C3(1)-bcl-2 transgene in progeny was identified by Southern blot and polymerase chain reaction (PCR) analysis. RNase protection assays were used to analyze RNA from 15 organs of these mice. Western blot assays and immunohistochemical staining were used to confirm the tissue-specific protein expression of human bcl-2 and its cellular localization.
  
  
  RESULTS
  Three lines of C3(1)-bcl-2 transgenic mice were established. Founder mice carried 2-20 copies of the transgene. Expression of human bcl-2 from the transgene was limited to the prostate gland and testis of males as well as the uterus of females. In the prostate gland, human bcl-2 protein was found only in prostatic epithelial cells. Microscopic analysis of prostate glands from individual males (three lines) showed that these glands were often abnormal, with increased accumulation of cells in the prostatic stroma as well as the epithelium.
  
  
  CONCLUSIONS
  These transgenic mice appear to provide a novel animal model for studying neoplastic development of the prostate, with particular emphasis on the bcl-2 protein and the role of apoptosis regulation in such development.
authors.affiliation: Department of Urology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
authors.forename: X
authors.initials: X
authors.lastname: Zhang
authors.forename: M W
authors.initials: MW
authors.lastname: Chen
authors.forename: A
authors.initials: A
authors.lastname: Ng
authors.forename: P Y
authors.initials: PY
authors.lastname: Ng
authors.forename: C
authors.initials: C
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Rubin
authors.forename: C A
authors.initials: CA
authors.lastname: Olsson
authors.forename: R
authors.initials: R
authors.lastname: Buttyan
mesh_terms: D000818:Animals; D017209:Apoptosis; D001345:Autoradiography; D015139:Blotting, Southern; D015153:Blotting, Western; D017931:DNA Primers; D018076:DNA, Complementary; D004195:Disease Models, Animal; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D010053:Ovary / Q000737:chemistry; D016133:Polymerase Chain Reaction; D011467:Prostate / Q000196:embryology* / Q000378:metabolism / Q000473:pathology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis* / Q000235:genetics; D013737:Testis / Q000737:chemistry
chemical_list: D017931:DNA Primers; D018076:DNA, Complementary; D019253:Proto-Oncogene Proteins c-bcl-2